Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Bruce David Walker, M.D.

Co-Author

This page shows the publications co-authored by Bruce Walker and Alex Shalek.
Connection Strength

1.001
  1. Evolution and Diversity of Immune Responses during Acute HIV Infection. Immunity. 2020 11 17; 53(5):908-924.
    View in: PubMed
    Score: 0.226
  2. Integrated single-cell analysis of multicellular immune dynamics during hyperacute HIV-1 infection. Nat Med. 2020 04; 26(4):511-518.
    View in: PubMed
    Score: 0.216
  3. Augmentation of HIV-specific T cell function by immediate treatment of hyperacute HIV-1 infection. Sci Transl Med. 2019 05 22; 11(493).
    View in: PubMed
    Score: 0.204
  4. Antiviral CD8+ T Cells Restricted by Human Leukocyte Antigen Class II Exist during Natural HIV Infection and Exhibit Clonal Expansion. Immunity. 2016 10 18; 45(4):917-930.
    View in: PubMed
    Score: 0.171
  5. Immunological Fingerprints of Controllers Developing Neutralizing HIV-1 Antibodies. Cell Rep. 2020 01 28; 30(4):984-996.e4.
    View in: PubMed
    Score: 0.054
  6. A Reproducibility-Based Computational Framework Identifies an Inducible, Enhanced Antiviral State in Dendritic Cells from HIV-1 Elite Controllers. Genome Biol. 2018 01 29; 19(1):10.
    View in: PubMed
    Score: 0.047
  7. Circulating CXCR5+CXCR3+PD-1lo Tfh-like cells in HIV-1 controllers with neutralizing antibody breadth. JCI Insight. 2017 01 26; 2(2):e89574.
    View in: PubMed
    Score: 0.043
  8. Innate Lymphoid Cells Are Depleted Irreversibly during Acute HIV-1 Infection in the Absence of Viral Suppression. Immunity. 2016 Feb 16; 44(2):391-405.
    View in: PubMed
    Score: 0.041
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.